A functional landscape of resistance to ALK inhibition in lung cancer. [electronic resource]
Producer: 20150522Description: 397-408 p. digitalISSN:- 1878-3686
- Anaplastic Lymphoma Kinase
- Carcinoma, Non-Small-Cell Lung -- drug therapy
- Cell Line, Tumor
- Crizotinib
- Drug Resistance, Neoplasm -- genetics
- ErbB Receptors -- genetics
- Humans
- Lung Neoplasms -- drug therapy
- Pyrazoles -- pharmacology
- Pyridines -- pharmacology
- Receptor Protein-Tyrosine Kinases -- antagonists & inhibitors
- Receptor, ErbB-2 -- genetics
- Receptors, Purinergic P2Y -- genetics
- Signal Transduction -- drug effects
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.